AZA Wildlife Contraception Center Programme for Wild Felids and Canids

    loading  Checking for direct PDF access through Ovid

Abstract

Contents

North American zoos began using melengestrol acetate (MGA) implants to control reproduction in wild felids in the mid-1970s. Research linking MGA and other progestin-based contraceptives to uterine and mammary pathology in canids as well as felids resulted in a shift to GnRH agonist implants (Suprelorin®: deslorelin, Peptech Animal Health, Australia). However, a recent study revealed an association between Suprelorin® and uterine pathology in canids, but that pathology was not found in canids treated with oral megestrol acetate (MA) for 2 weeks around the time of implant insertion to prevent the initial agonist stimulation phase. Thus, the AZA Wildlife Contraception Center (WCC) currently recommends Suprelorin® plus the 2-week MA regimen for wild canids and felids. WCC research is now focusing on factors affecting Suprelorin® reversibility.

Related Topics

    loading  Loading Related Articles